Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose valsartan for sympathetic hyperactivity in chronic kidney disease and hypertension
2008-000628-25Phase 3Active
- Sponsor
- University Medical Center Utrecht
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of valsartan in hypertension (HTN) and chronic kidney disease (CKD) (2 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Change in muscle sympathetic nerve activity. Started May 2008; status: active.
02
Drugs
valsartan
03
Conditions
hypertension (HTN)chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2008-000628-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000628-25.